top of page


140. Lee, Seonghyun et al. and Mee-Sup Yoon*, Byung-Kwan Lim*, and Jae-Hwan Nam*, “Assessing the impact of mRNA vaccination in chronic inflammatory murine model.” NPJ vaccines vol. 9,1 34. 15 Feb. 2024, doi:10.1038/s41541-024-00825-z (*Corresponding author)

139. Sang-In Park et al. and Jae-Hwan Nam*, “Intranasal immunization with the recombinant measles virus encoding the spike protein of SARS-CoV-2 confers protective immunity against COVID-19 in hamsters.” Vaccine vol. 42,2 (2024): 69-74. doi:10.1016/j.vaccine.2023.12.011 

(*Corresponding author)



138. Sang-Yeon Lee et al. and Jae-Hwan Nam*, “The Adenylyl Cyclase Activator Forskolin Increases Influenza Virus Propagation in MDCK Cells by Regulating ERK1/2 Activity.” Journal of microbiology and biotechnology vol. 33,12 (2023): 1576-1586. doi:10.4014/jmb.2306.06027 (*Corresponding author)

137. Seonghyun Lee et al. Shee Eun Lee*, and Jae-Hwan Nam*, “mRNA-HPV vaccine encoding E6 and E7 improves therapeutic potential for HPV-mediated cancers via subcutaneous immunization.” Journal of medical virology vol. 95,12 (2023): e29309. doi:10.1002/jmv.29309 (*Corresponding author)

136. Hye Won Kwak et al. Sang-Myeong Lee*, So-Hee Hong*, and Jae-Hwan Nam*, “Corrigendum to "Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants" [Vaccine 41(11) (2023) 1892-1901].” Vaccine vol. 41,47 (2023): 7033. doi:10.1016/j.vaccine.2023.10.033 (*Corresponding author)

135. Jae-Yong Kim et al. Nam-Hyuk Cho, and Jae-Hwan Nam*, “mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice.” NPJ vaccines vol. 8,1 167. 31 Oct. 2023, doi:10.1038/s41541-023-00771-2 (*Corresponding author)

134. Yu-Sun Lee et al., Jae-Hwan Nam*, and So-Hee Hong*, Analysis of the Immunostimulatory Effects of Cytokine-Expressing Internal Ribosome Entry Site–Based RNA Adjuvants and Their Applications, The Journal of Infectious Diseases, 2023;, jiad392, (*Corresponding author)

133. Inseong Choi, Guk-Young Ahn, Eun Seo Kim, Se Hee Hwang, Hyo-Jung Park, Subin Yoon, Jisun Lee, Youngran Cho, Jae-Hwan Nam, and Sung-Wook Choi*. Nano Letters 2023 23 (17), 7897-7905. DOI: 10.1021/acs.nanolett.3c01699(*Corresponding author)

132. Lee, J., Woodruff, M.C., Kim, E.H., and Nam JH*. Knife’s edge: Balancing immunogenicity and reactogenicity in mRNA vaccines. Exp Mol Med 55, 1305–1313 (2023).*Corresponding author)

131. Park, HJ., Bang, YJ., Kwon, S.P. et al. and Nam JH*. Analyzing immune responses to varied mRNA and protein vaccine sequences. npj Vaccines 8, 84 (2023). (*Corresponding author)

130. Kim, JY., Jeon, K., Hong, J.J. et al. and Nam JH*. Heterologous vaccination utilizing viral vector and protein platforms confers complete protection against SFTSV. Sci Rep 13, 8189 (2023). (*Corresponding author)


129. Kwak H.W. et al. and Nam JH*. Recombinant measles virus encoding the spike protein of SARS-CoV-2 efficiently induces Th1 responses and neutralizing antibodies that block SARS-CoV-2 variants. Vaccine Volume 41, Issue 11, 10 March 2023, Pages 1892-1901 (2023). (*Corresponding author)




128. Kwak H.W. et al. and Nam JH*. Adjuvant effect of IRES-based single-stranded RNA on melanoma immunotherapy. BMC Cancer 22, 1041 (2022). (*Corresponding author)


127. Kwak HW, Shin W, Baik K, Kim M, Park Y, Hong SH, Park HJ, Park HJ, Bang YJ, Kim JY, Lee YS, Kim IB, Kim HL, Kim H, Nam JH*. Single-stranded RNA adjuvant enhances the efficacy of 10-valent human papilloma virus-like particle vaccine. Microbiol Immunol. 2022 Nov;66(11):529-537. doi: 10.1111/1348-0421.13024. Epub 2022 Sep 5. PMID: 35979884. (*Corresponding author)


126. Influenza vaccines: Past, present, and future. Yun-Hee Kim et al. and Nam JH* Reviews in Medical Virology. 2022, e2243 (*Corresponding author)




125. Peptides Derived From S and N Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Induce T Cell Responses: A Proof of Concept for T Cell Vaccines. Yu-Sun Lee et al. and Nam JH*. Frontiers in Microbiology. 24 September 2021 | p2798 (*Corresponding author)


124. Immune Responses to Varicella Zoster Virus and Effective Vaccines. Su Jeen Lee et al. and Nam JH* Journal of Bacteriology and Virology. 2021/9, 51(3):103-111. (*Corresponding author)


123. Next‐Generation Sequencing for Typing Human Papillomaviruses and Predicting Multi‐Infections and Their Clinical Symptoms. Sang-Yeon Kim et al. and Nam JH* Microbiology and Immunology. 16 June 2021, Volume65, Issue7 Pages 273-278 (*Corresponding author)


122. Effective inactivated influenza vaccine for the elderly using a single-stranded RNA-based adjuvant. Yoo-Jin Bang et al. and Nam JH* Scientific reports. 07 June 2021, 11:11981 | (*Corresponding author)


120. Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates. So-Hee Hong et al, and Jae-Hwan Nam* Science Advances. 28 May 2021:Vol. 7, no. 22, eabg7156 DOI: 10.1126/sciadv.abg7156 (*Corresponding author)


119. Neutralizing Antibodies to Severe Fever With Thrombocytopenia Syndrome Virus Among Survivors, Non-Survivors and Healthy Residents in South Korea. Jeong Rae Yoo, Jae-Yong Kim, Sang Taek Heo, Jihye Kim, Hyeong-Jun Park, Joo-Yeon Lee, Hee-Young Lim, Woo-Jung Park, Nam-Hyuk Cho, Jung Mogg Kim, Keun Hwa Lee. and Nam JH* Front. Cell. Infect. Microbiol. 23 March 2021, 11:649570. doi: 10.3389/fcimb.2021.649570 (*Corresponding author)




118. Inactivated influenza vaccine formulated with single-stranded RNA-based adjuvant confers mucosal immunity and cross-protection against influenza virus infection. Yun-Hee Kim et al. and Nam JH* Vaccine. Volume 38, Issue 39, 3 September 2020, Pages 6141-6152 (*Corresponding author)


117. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant. Su Jeen Lee et al. and Nam JH* Immun Inflamm Dis. 2020 Jun;8(2):216-227. (*Corresponding author)


116. Lessons Learned from SARS-CoV and MERS-CoV: Preparation for SARS-CoV-2 induced COVID-19. Hong SH, Park HJ and Nam JH* J Bacteriol Virol. 2020 Jun;50(2):76-96 (*Corresponding author)


115. What we know and what we need to know about adenovirus 36-induced obesity. Jihye Kim, Hana Na, Jung-Ae Kim and Nam JH* International Journal of Obesity 2020 Jan. (*Corresponding author)


114. Insight into the relationship between obesity-induced low-level chronic inflammation and COVID-19 infection. Jihye Kim and Nam JH* Int J Obes (Lond) 2020 May 22:1-2. (*Corresponding author)


113. Recent advances in vaccines and diagnostics against Middle East respiratory syndrome coronavirus. K Lee and Nam JH* Acta Virol. 2020;64(2):251-260. (*Corresponding author)


112. MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice. Hye-Jung Kim et al. and Nam JH* Pharmaceutics 2020 May 10;12(5):441. (*Corresponding author)


111. Nanoformulated Single-Stranded RNA-Based Adjuvant with a Coordinative Amphiphile as an Effective Stabilizer: Inducing Humoral Immune Response by Activation of Antigen-Presenting Cells. Hyo-Jung Park et al. and Jae-Hwan Nam* Angew Chem Int Ed Engl. 2020 Jul 6;59(28):11540-11549. (*Corresponding author)


110. Evaluation of Multiplex Polymerase Chain Reaction Assay for the Simultaneous Detection of Sexually Transmitted Infections Using Swab Specimen. Park SH, Hwang KA, Ahn JH and Nam JH* J Bacteriol Virol. 2020 Mar;50(1):44-54. (*Corresponding author)




109. Comprehensive Analysis of the Safety Profile of a Single-Stranded RNA Nano-Structure Adjuvant. Park HJ, Ko HL, Won DH, Hwang DB, Shin YS, Kwak HW, Kim HJ, Yun JW, Nam JH* Pharmaceutics 2019 Sep 7;11(9). pii: E464. doi: 10.3390/pharmaceutics11090464.


108. Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1/Th2 response. Kwak HW, Park HJ, Ko HL, Park H, Cha MH, Lee SM, Kang KW, Kim RH, Ryu SR, Kim HJ, Kim JO, Song M, Kim H, Jeong DG, Shin EC, Nam JH* Vaccine 2019 Aug 23;37(36):5191-5202. doi: 10.1016/j.vaccine.2019.07.070. Epub 2019 Jul 29.


107. Development of an RNA Expression Platform Controlled by Viral Internal Ribosome Entry Sites. Ko HL, Park HJ, Kim J, Kim H, Youn H, Nam JH* J Microbiol Biotechnol. 2019 Jan 28;29(1):127-140. doi: 10.4014/jmb.1811.11019..




106. Development and validation of multiplex real-time PCR assays for rapid detection of cytomegalovirus, Epstein-Barr virus, and polyomavirus BK in whole blood transplant candidates. Kyung-Ah Hwang, Ji Hoon Ahn, and Jae-Hwan Nam*. Journal of Microbiology 2018 Jun. 56(8) 593–599 (*Corresponding author)


105. Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Seo-Yeon Jung, Kyeong-Won Kang, Eun-Young Lee, Dong-Won Seo, Hong-Lim Kim, Hak Kim, TaeWoo Kwon, Hye-Lim Park, Hun Kim, Sang-Myeong Lee, Jae-Hwan Nam* Vaccine 2018 Jun 7;36(24):3468-3476 (*Corresponding author)


104. Development of a standard protocol for quantitative polymerase chain reaction to detect adenovirus 36, which is associated with obesity. Kyung-Ah Hwang, Sooho Park, Ji Hoon Ahn, and J-H Nam* Acta Virologica 2018 in printing (*Corresponding author)


103. Diagnosis of Viral Infection Using Real-time Polymerase Chain Reaction Kyung-A Hwang, Ji Hoon Ahn, Jae-Hwan Nam* Journal of Bacteriology and Virology 2018 Mar;48(1):1-13 (*Corresponding author)


102. Effect of apoptosis-associated speck-like protein containing a caspase recruitment domain on vaccine efficacy: overcoming the effects of its deficiency with aluminum hydroxide adjuvant. Deuk-Ki Lee, Eun-Young Lee, Ryoon-Ho Kim, Hye-Won Kwak, Joo Young Kim, Hun Kim, Kyung-Won Kang, Sang-Myeong Lee, Jong-Hwan Park, Jun Chang, Jae-Hwan Nam* Microbiol Immunol. 2018 Mar;62(3):176-186. (*Corresponding author)




101. Therapeutic Effect of Exogenous Truncated IK Protein in Inflammatory Arthritis. Seulgi Choi, HyeLim Park, SeoYeon Jung, Eun-Kyung Kim, Mi-Ra Cho, Jun-Ki Min, Su-Jin Moon, Sang-Myeong Lee, Jang-Hee Cho, Dong-Hee Lee and Jae-Hwan Nam* International Journal of Molecular Sciences. 2017. 18(9). pii: E1976. (*Corresponding author)


100. Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis. IL-Sub Yoon, Hyelim Park, Hye-Won Kwak, Yong Woo Jung, and Jae-Hwan Nam* Vaccine. 2017. 35:4687-4694 (*Corresponding author)


99. Human rhinoviruses: the forgotten but still important viruses. Hak Kim and Jae-Hwan Nam* Journal of Bacteriology and Virology 2017. 47(3) 111-121 (*Corresponding author)


98. Insulin-sparing and fungible effects of E4orf1 combined with an adipocyte-targeting sequence in mouse models of type 1 and type 2 diabetes. Il-Sub Yoon, Sooho Park, Ryoon-Ho Kim, Hae Li Ko, and Jae-Hwan Nam* International Journal of Obesity. 2017 41(10):1601-1605. (*Corresponding author)


97. Recombinant adeno-associated virus expressing truncated IK cytokine diminishes the symptoms of inflammatory arthritis. Seulgi Choi, Hyelim Park, Marstella Minelko, Eun-Kyung Kim, Mi-Ra Cho, Jae-Hwan Nam*. J Microbiol Biotechnol. 2017 doi: 10.4014/jmb.1705.05018. (*Corresponding author)


96. IK acts as an immunoregulator of inflammatory arthritis by suppressing TH17 cell differentiation and macrophage activation. Park HL, Lee SM, Min JK, Moon SJ, Kim I, Kang KW, Park S, Choi S, Jung HN, Lee DH, Nam JH*. Scientific Reports. 2017 Jan 10;7:40280. doi: 10.1038/srep40280. (*Corresponding author)




95. Sublingual immunization with Japanese encephalitis virus vaccine effectively induces immunity through both cellular and humoral immune responses in mice. Lee EY, Kim JY, Lee DK, Yoon IS, Ko HL, Chung JW, Chang J, Nam JH*. Microbiol Immunol. 2016 Dec;60(12):846-853 (*Corresponding author)


94. The Characteristics of RNA Vaccine; its Strengths and Weaknesses. Hyo-Jung Park, Hae Li Ko, Seo-Yeon Jung, Han-Byeol Jo and Jae-Hwan Nam*. Journal of Bacteriology and Virology 2016. 46(3):115-127 (*Corresponding author)


93. Diet-induced obesity reduces the production of influenza vaccine-induced antibodies via impaired macrophage function. WJ CHO, DK LEE, SY LEE, SH SOHN, HL PARK, YW PARK, H KIM, JH Nam* Acta Virologica. 2016. 60:298-306 (*Corresponding author)


92. Characteristics of adipose tissue macrophages and macrophage-derived insulin-like growth factor-1 in virus-induced obesity. Park S, Park HL, Lee SY, Nam JH*. International Journal of Obesity. 2016 Mar 40: 460-470 (*Corresponding author)




91. Influence of the Host Factors on Human Papillomavirus Infection and Vaccine Efficacy. Sung-Hwa Sohn and Jae-Hwan Nam*. Journal of Bacteriology and Virology 2015 45(3): 179-188 (*Corresponding author)


90. The effect of lipopolysaccharide-induced obesity and its chronic inflammation on influenza virus-related pathology. Ahn SY, Sohn SH, Lee SY, Park HL, Park YW, Kim H, Nam JH. Environ Toxicol Pharmacol. 2015 Oct 22;40(3):924-930. (*Corresponding author)


89. Tracking study about adenovirus 36 infection: increase of adiposity. Park S, Kim J, Shin HJ, Hong YM, Shin YH, Park HL, Jeon HJ, Ahn SY, Nam JH. J Microbiol Biotechnol. 2015 Oct 2. 25(12):2169-2172 (*Corresponding author)


88. Apios americana Medik extract alleviates lung inflammation in influenza virus H1N1- and endotoxin-induced acute lung injury. Sohn SH, Lee SY, Cui J, Jang HH, Kang TH, Kim JK, Kim IK, Lee DK, Choi S, Yoon IS, Chung JW, Nam JH. J Microbiol Biotechnol. 2015 Oct 2. 25(12):2146-2152 (*Corresponding author)


87. Cardiovascular screening in asymptomatic adolescents with metabolic syndrome. Bae HK, Choi HS, Sohn S, Shin HJ, Nam JH, Hong YM. J Cardiovasc Ultrasound. 2015 Mar;23(1):10-19.




86. Is Obesity One of Physiological Factors which Exert Influenza Virus-induced Pathology and Vaccine Efficacy? Whajung Cho, Jae-Hwan Nam. Journal of Bacteriology and Virology 2014 Sep 44(3):226-235 (*Corresponding author)


85. Human adenovirus Ad36 and its E4orf1 gene enhance cellular glucose uptake even in the presence of inflammatory cytokines. Na HN, Dubuisson O, Hegde V, Nam JH, Dhurandhar NV. Biochimie. 2014 Nov 15. pii: S0300-9084(14)00334-4.


84. Associations of matrix metalloproteinase (MMP)-8; MMP-9; and their inhibitor, tissue inhibitor of metalloproteinase-1, with obesity-related biomarkers in apparently healthy adolescent boys. Youn Ho Shin, Ki Eun Kim, Yong-Jae Lee, Jae-Hwan Nam, Young Mi Hong, Hye-Jung Shin. Korean J Pediatr 2014 December;57(12):526-532.


83. Adenovirus 36 Attenuates Weight Loss from Exercise but Improves Glycemic Control by Increasing Mitochondrial Activity in the Liver. Ha-Na Na, Young-Mi Hong, Michael B. Ye, SooHo Park, In-Beom Kim, Jae-Hwan Nam* PLos One 2014 Dec 5;9(12):e114534 (*Corresponding author)


82. Coxsackievirus B3 regulates T-cell infiltration into the heart by lymphocyte function-associated antigen-1 activation via the cAMP/Rap1 axis. Shim SH, Kim DS, Cho W, Nam JH*. J Gen Virol. 2014 Sep;95(Pt 9):2010-18. (*Corresponding author)


81. Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36. Na HN, Nam JH*. Int J Obes. 2014 Nov;38(11):1470-4 (*Corresponding author)

80. Reduction of adenovirus 36-induced obesity and inflammation via the use of mulberry extract. Na HN, Park S, Jeon HJ, Kim HB, Nam JH*. Microbiol Immunol. 2014 May;58(5):303-6. (*Corresponding author)


79. Obesity-induced Chronic Inflammation is Associated with the Reduced Efficacy of Influenza Vaccine. Hye-Lim Park, Seung-Hyun Shim, Eun-Young Lee, Wha-Jung Cho, Sooho Park, Hyun-Jung Jeon, Sun-Young Ahn, Hun Kim and Jae-Hwan Nam* Human Vaccines & Immunotherapeutics 2014. 10(5): 1181-1186. (*Corresponding author)


78. Prophylactic and therapeutic vaccines for obesity. Na HN, Kim H, Nam JH. Clin Exp Vaccine Res. 2014 Jan;3(1):37-41.


77. Genomic stability of adipogenic human adenovirus 36. Jae-Hwan Nam*, Ha-Na Na, Richard L. Atkinson, Nikhil V. Dhurandhar*. International Journal of Obesity. 2014 3(1):37-41 (*Co-Corresponding author)




76. Novel Role of Invariant Natural Killer T-cell in Glycemic Control: Regulation by human Adenovirus 36. Sooho Park and Jae-Hwan Nam*. Journal of Bacteriology and Virology 2013. 43(3):229-232 (*Corresponding author)


75. The yesterday, today, and tomorrow of pathogen-induced obesity. Ha-Na Na and Jae-Hwan Nam* The Korean Journal of Obesity 2013 22(4):187-196. (*Corresponding author)


74. Histone deacetylase inhibitors suppress coxsackie virus B3 growth in vitro and myocarditis induced in mice. S.-H. SHIM, J.-H. PARK, M. B. YE, J.-H. NAM*. Acta Virologica. 2013. 57:462-466 (*Corresponding author)


73. Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system. Ha-Na Na, Kyung Hyun Kim, Man Ki Song, Hye-lim Park, Eun-young Lee, Seung-Hyun Shim, Sooho Park and Jae-Hwan Nam* Microbiology and Immunology. 2013, 57(9):660-4 (*Corresponding author/Cover Figure)


72. Harnessing the Beneficial Properties of Adipogenic Microbes for Improving Human Health. Dhurandhar NV, Geurts L, Atkinson RL, Casteilla L, Clement K, Gerard P, Vijay-Kumar M, Nam JH, Nieuwdorp M, Trovato G, Sørensen TIA, Vidal-Puig A, Cani PD. Obesity Reviews. 2013 14(9): 721-735.


71. Why is not there a match between the serological and genomic prevalence of adenovirus 36? Nam JH. J Clin Virol. 2013, 56:370-371


70. IK induced by Coxsackievirus B3 infection transiently down-regulates expression of MHC class II through increasing cAMP. Hye-Lim Park, Yeon-Jung Kim, Ha-Na Na, Mi-Young Park, Joo-Young Kim, Cheol-Won Yun, Jae-Hwan Nam* Viral Immunology. 2013 26;1:13-24 (*Corresponding author)




69. Black soybean anthocyanins inhibit adipocyte differentiation in 3T3-L1 cells. Kim HK, Kim JN, Han SN, Nam JH, Na HN, Ha TJ. Nutr Res. 2012, Oct;32(10):770-7.


68. A peptide vaccine based on a B-cell epitope on the VP1 protein of enterovirus 70 induces a strong antibody response. Park KB, Lim BK, Ye MB, Chung SY, Nam JH*. Acta Virol. 2012;56(4):337-42. (*Corresponding author)


67. Development of an in vitro antigen-detection test as an alternative method to the in vivo plaque reduction neutralization test for the quality control of Japanese encephalitis virus vaccine. DoKeun Kim, Hye-Youn Kim, Joo-Young Kim, Michael B. Ye, Kee-Bum Park, Euiri Han, Jae Ok Kim, Sang Ja Ban, Seung-Hwa Hong, Yong Keun Park, and Jae-Hwan Nam* Microbiology and Immunology 2012, 56(7):463-471 (*Corresponding author)


66. Coxsackievirus B3 used as a gene therapy vector to express functional FGF2. D-S Kim, H Kim, S-H Ssim, C Kim, M Song, Y-H Kim, Y-W Jung, and J-H Nam* Gene Therapy. 2012 Apr;44(2):176-82 (*Corresponding author)


65. Adenovirus 36 as an Obesity Agent Maintains the Obesity State by Increasing MCP-1 and Inducing Inflammation. Ha-Na Na and Jae-Hwan Nam* Journal of Infectious Diseases. 2012, 205:914-922 (*Corresponding author)


64. A mechanism of immunoreceptor tyrosine-based activation motif (ITAM)-like sequences in the capsid protein VP2 in viral growth and pathogenesis of Coxsackievirus B3. Dae-Sun Kim, Jung-Hyun Park, Joo-Young Kim, DoKeun Kim, Jae-Hwan Nam* Virus Genes. 2012, 44:176-182 (*Corresponding author)


59. Novel genes and cellular pathways related to infection with adenovirus-36 as an obesity agent in human mesenchymal stem cells. Ha-Na Na, Hyongbum Kim, and Jae-Hwan Nam* International J Obesity. 2012 36:195-200 (*Corresponding author)




63. Regulation of innate immunity via MHC class II-mediated signaling; Non-classical role of MHC class II in innate immunity. Hye-Lim Park and Jae-Hwan Nam* Journal of Bacteriology and Virology. 2011, 41:3:1-3. (*Corresponding author)


62. Infectobesity: a new area for microbiological and virological research. Ha-Na Na and Jae-Hwan Nam* Journal of Bacteriology and Virology. 2011, 41:2:65-76. (*Corresponding author)


61. Development of a Gene Therapy Method for Cervical Cancer Using Attenuated Coxsackievirus B3 as a Vector System. Seung-Hyun Shim, Yeon-Jung Kim, Dae-Sun Kim, Jae-Hwan Nam* Journal of Bacteriology and Virology. 2011, 41:2:123-130. (*Corresponding author)


60. RNA interference to granulin–epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent. MI-YOUNG PARK, YOON SHIN PARK, Jae-Hwan Nam* International J Oncology. 2011, 39:853-861. (*Corresponding author)


58. Association of human adenovirus-36 in overweight Korean adults. Ha-Na Na, Jihye Kim, Hong Soo Lee, Kyung Won Shim, Heejin Kimm, Sun Ha Jee, Inho Jo, Jae-Hwan Nam*. International J Obesity. 2011 36:281-285. (*Corresponding author)


57. Chk1 and Hsp90 cooperatively regulate phosphorylation of endothelial nitric oxide sysnthease at serine 1179. J-H Park, W-S Kim, J Y Kim, M-H Park, Jae-Hwan Nam, C-W Yun, Y-G Kwon, I Jo. Free Radical Biology & Medicine 2011 51(12):2217-2226


56. Transcription Factor Sp1 Is Involved in Expressional Regulation of Coxsackie and Adenovirus Receptor in Cancer Cells. Sun-Ku Chung, Joo-Young Kim, Joong-Yeon Lim, Young Mi Park, Ha-Young Hwang, Jae Hwan Nam and Sang Ick Park. Journal of Biomedicine and Biotechnology. 2011;2011:636497


55. Application of attenuated coxsackievirus B3 as a viral vector system for vaccines and gene therapy. Dae-Sun Kim & Jae-Hwan Nam* Human vaccines. 2011 Apr. 1; 7(4): 410-416. (*Corresponding author)




54. Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Ha-Na Na, Young-Mi Hong, Ji-Hye Kim, Hye-Kyeong Kim, Inho Jo, Jae-Hwan Nam*. International Journal of Obesity. 34:89-93, 2010. (*Corresponding author)


53. Systemic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector. D-S Kim, Y-J Cho, B-G Kim, S-H Lee, Jae-Hwan Nam* Vaccine 28:1234-1240, 2010. (*Corresponding author)


52. Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines. Dae-Sun Kim, Jae-Hwan Nam* Expert Opinion on Biological Therapy. 10(2):179-190, 2010 (*Corresponding author)




51. Rapamycin, an immunosuppressant used in transplantation, paradoxically stimulates memory CD8 T cells: could it enhance vaccine efficacy? (Key paper evaluation). Jae-Hwan Nam. Expert Review of Vaccine. 8(11):1535-1539. 2009 (*Corresponding author)


50. The PrM-independent packaging of pseudotyped Japanese encephalitis virus. H-J Lee, K-I Min, S-H Kang, W Jwon, J-H Nam, Y-R Ju, Y-B Kim. Virology Journal. 6:115. 2009


49. Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis Jung-Hyun Park, Dae-Sun Kim, Young-Joo Cho, Yeon-Jung Kim, Soo-Young Jeong, Seug-Min Lee, Seong-Joo Cho, Cheol-Won Yun, Inho Jo, and Jae-Hwan Nam* Vaccine 27,1974-1983. 2009 (*Corresponding author)


48. Systemic analysis of a novel coxsackievirus gene delivery system in mouse model. KIM, YEON-JUNG, SOO-HYEON YUN, BYUNG-KWAN LIM, KI-BUM PARK, HA-NA NA, SOO-YOUNG JEONG, DAE-SUN KIM, YOUNG-JOO CHO, EUN-SEOK JEON, AND Jae-Hwan Nam* Journal of Microbiology and Biotechnology 19:307-313. 2009 (*Corresponding author)




47. Real-time RT-PCR of Hantaan virus RNA used for the detection of virus response to antiviral drugs. JH Nam, CH Yu, K.A. Hwang, Y.R. Ju, 2008 Acta Virologica. 52:67-70


46. Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model. Yeon-Jung Kim, Jeonghyun Ahn. Soo-Young Jeungl, Dae-Sun Kim, Ha-Na Na, Young-Joo Cho, Soo-Hyeon Yun, Youngmee Jee, Eun-Seok Jeon, Heuiran Lee, Jae-Hwan Nam* Virus Genes. 2008, 36:141-146 (*Corresponding author)




45. Production of Cross-Reactive Peptide Antibodies against Viral Capsid Proteins of Human Enterovirus B to Apply Diagnostic Reagent. Soo-Young Jeong, Jeonghyun Ahn, Young-Joo Cho, Yeun-Jung Kim, Dae-Sun Kim, Youngmee Jee, Heuiran Lee, and Jae-Hwan Nam* Microbiology and Immunology 2007. 51:1091-1098 (*Corresponding author)


44. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant MVA vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccine. JH Nam, HS Bang, HW Cho, YH Chung. Acta Virologica 2007. 51:125-130


43. Expression of short hairpin RNAs against the coxsackievirus B3 exerts potential antiviral effects in Cos-7 cells and in mice. Kim JY, Chung SK, Hwang HY, Kim H, Kim JH, Nam JH, Park SI. Virus Res 2007. 125:9-13


42. Coxsackievirus B3 Modulates Cell Death by Downregulating Activating Transcription Factor 3 in HeLa Cells. Ha Young Hwang, Joo-Young Kim, Joong-Yeon Lim, Sun-Ku Chung, Jae-Hwan Nam, Sang Ick Park. Virus Research 2007 130:10-17




41. Virus receptor trap neutralize Coxsackievirus in experimental viral myocarditis. BK Lim, JH Choi, JH Nam, CO Gil, JO Shin, SH Yun, DK Kim, ES Jeon. Cardiovascular Research 2006. 71:517-526


40. Role of protein kinase C delta in an early stage of coxsackievirus-B3-induced apoptosis in HeLa cells. PARK, JUNG-HYUN, DU-HYONG CHO, CHEOL-WON YUN, JAE-WON SOH, YOUNG MEE JEE, SANG-IK PARK, INHO JO AND Jae-Hwan Nam*. J Microbiology and Biotechnology 2006, 16(4):550-555 (*Corresponding author)


39. Host gene profiling of coxsackievirus B3 H3 and 10A1 infected mouse heart. JH Nam, BK Lim, YJ Cho, DS Kim, YJ Kim, SY Chung, YM Jee, ES Jeon. J Bacteriology and Virology 2006, 36(2):89-98


38. Development of peptide antibody against coxsackievirus B3 VP2. SY Chung, YJ Cho, YJ Kim, DS Kim, H Lee, JH Nam*. J Bacteriology and Virology 2006, 36(2):109-117 (*Corresponding author)


37. 노윤태, 조정은, 한명국, 이나연, 김수연, 주재신, 이호동, 남재환, 박근용, 신영학, 조해월, 송현제, 주영란 “1996년부터 2005년까지 혈청학적검사로 진단된 신증후출혈열의 역학적 특성 분석” J Bacteriology & Virology 36(4), 263-269, 2006




36. Analysis of Integrity of Killed Hantavirus Vaccine by Antigen-Capture Reverse Transcriptase PCR. HWANG KYUNG-A, YOUNG-RAN JOO, YOUNG-HAK SHIN, KEUN-YONG PARK AND Jae-Hwan Nam* J Microbiology and Biotechnology 15(6):1384-1387, 2005 (*Corresponding author)


35. TGF-beta1 induces cardiac hypertrophic responses via PKC depedent ATF-2 activation. Lim JY, Park SJ, Hwang HY, Park EJ, Nam JH, Kim J, Park SI. J Mol Cell Cardiol 2005 39(4):627-636


34. Coxsackievirus B3 replication is related to activation of the late Extracellular Signal-Regulated Kinase (ERK) Signal. Byung-Kwan Lim, Jae-Hwan Nam, Chae-Ok Gill, Duk-Kyung Kim and Eun-Seok Jeon. Virus Research 2005 113(2):153-157. BK Lim and JH Nam are equally contributed


33. The role of ERK1/2 activation in the infection of HeLa cells with human Coxsackievirus B3. S-K Kim, E-J Kim, S-I Park, J-H Nam* Acta Virologica 2005. 49:91-96. (*Corresponding author)


32. Internalization and trafficking mechanisms of Coxsackievirus B3 in HeLa cells. Sun-Ku Chung, Joo-Young Kim, In-Beom Kim, Sang-Ick Park, Jae-Hwan Nam* Virology 2005. 333:1;31-40. (*Corresponding author)


31. Retinoic acid decreases nitric oxide production in endothelial cells: a role of phosphorylation of endothelial nitric oxide synthases at Ser(1179). Du-Hyong Cho, YoonJung Choi, Sangmee A Jo, Jae-Hwan Nam, Sung-Chul Jung, Inho Jo. Biochemical and Biophysical Research Communications 2005. 326;703-710.




30. Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death. Sun-Mi Kim, Jung-Hyun Park, Sun-Ku Chung, Joo-Young Kim, Ha-Young Hwang, Kwang-Chul Chung, Inho Jo, Sang-Ik Park, and Jae-Hwan Nam*. Journal of Virology 2004. 78:24; 13479-13488. (*Corresponding author.)


29. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge. Joo-Young Kim, Eun-Seok Jeon, Byung-Kwan Lim, Sun-Mi Kim, Sun-Ku Chung, Jong-Mook Lim, Sang-Ick Park, Inho Jo, Jae-Hwan Nam*. Vaccine 2005. 23;1672-1679. (*Corresponding author.)


28. In Vivo Analysis of the 3’ Untranslated Region of GB Virus-B after In Vitro Mutagenesis of an Infectious cDNA Clone: persistent Infection in a Transfected Tamarin. Jae-Hwan Nam, Kristina Faulk, Ronald E. Engle, Sugantha Govindarajan, Marisa St. Claire and Jens Bukh. Journal of Virology 2004. 78:9389-9399.


27. Polymorphisms of the prion protein gene (PRNP) in a Korean population. Byung-Hoon Jeong, Jae-Hwan Nam, Yun-Jung Lee, Kyung-Hee Lee, Myoung-Kuk Jang, Richard I. Carp, Ho-Dong Lee, Young-Ran Ju, Sangmee Ahn Jo, Keun-Yong Park and Yong-Sun Kim. J. Human Genetics. 2004. 49(6):319-324.


26. Application of Hantavirus N protein expressed by E. Coli system. CH Yu, JH Nam*, TK Choi, YR Ju, CH Lee, YH Shin, KY Park. J Bacteriology and Virology. 2004.34:147-155. (*Corresponding author)




25. Molecular characterization of the full-length of the Japanese encephalitis viral strain K87P39. Yun SI, Kim SY, Choi WY, Nam JH, Ju YR, Park KY, Cho HW, Lee YM. Virus Research 2003. 96(102):129-140.


24. Expression of interferon inducible genes following Hantaan virus infection as a mechanism of resistance in A549 cells. JH Nam, KA Hwang, JH Yu, TH Kang, JY Shin, WY Choi, IB Kim, YR Joo, HW Cho and KY Park. 2003. Virus Genes 26(1):31-38


23. Application of cDNA microarray technique to detection of gene expression in host cells infected with virus. JH Nam, CH Yu, KA Hwang, JS Kim, SH Ahn, JY Shin, WY Choi, YR Joo, KY Park. 2002. Acta Virologica. 46:141-146


22. Serologic and Genetic Characterization of Hantavirus from Apodemus mice Captured in Kyonggi-do and Gangwon-do, 2001. JH Nam, CH Yu, KA Hwang, JE Chun, TK Choi, WY Choi, IB Kim, CH Lee, YR Ju, KY Park. 2002. J of Bacteriology and Virology 32: 83-92.


21. Expression and purification of glycoprotein G1 of Hantaan virus in E. coli system. GR Choi, JH Nam, WY Choi, YR Ju, KY Park, HW Cho. 2002. J of Bacteriology and Virology 32:421-429.


20. Immunogenicity of a recombinant MVA and a DNA vaccine for Japanese encephalitis virus in Swine. JH Nam, SL Chae, HW Cho. 2002. Microbiology and Immunology 46(1), 23-28.


19. High level of sequence variation in the 3’ non-coding region of Japanese encephalitis viruses isolated in Korea. JH Nam, SL Chae, SH Park, YS Jeong, MS Joo, CY Kang, HW Cho. 2002. Virus Genes. 24:1, 21-27.




18. Genetic heterogeneity of Japanese encephalitis virus assessed via analysis of the full-length genome sequence of a Korean isolate. JH Nam, SL Chae, SY Won, EJ Kim, KS Yoon, BI Kim, YS Jeoung, HW Cho. 2001. Am. J. Trop. Med. Hyg 65: 388-392


17. Elicitation of high frequency Cytotoxic T-Lymphocyte responses against both dominant and subdominant Simian-Human Immunodeficiency virus epitopes by DNA vaccination of Rhesus monkeys. DH Barouch, A Craiu, S Santra, MA Egan, JE Schmitz, MJ Kuroda, TM Fu, JH Nam, LS Wyatt, MA Lifton, GR Krivulka, CE Nickerson, CI Lord, B Moss, MG Lewis, VM Hirsch, JW Shiver, NL Letvin. 2001. J. Virol. 75: 2462-2467


16. Reduction of Simian-Human Immunodeficiency virus 89.6P viremia in Rhesus monkeys by recombinant modified vaccinia ankara (MVA) vaccination. DH Barouch, S Santra, MJ Kuroda, JE Schmitz, R Plishka, A Buckler-White, AE Gaitan, R Zin, JH Nam, LS Wyatt, MA Lifton, CE Nickerson, B Moss, DC Montefiori, VM Hirsch, NL Letvin. 2001. J. Virol. 75: 5151-5158.


15. High-level expression of HCV structural proteins by a chimeric HCV/BVDV genome propagated as a BVDV pseudotype. JH Nam, SU Emerson, RH Purcell, J Bukh. 2001. J Virol. Method 97: 113-123.


14. Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes. JH Nam, L S Wyatt, SL Chae, HW Cho, YK Park, B Moss. Vaccine 17 (1999) 261-268.


13. Analysis of the three dimensional structure of envelope protein of the Japanese encephalitis virus isolated in Korea. JH Nam, SL Chae, EJ Kim, KS Yoon, HD Lee, HC Koh, HW Cho. 1997, J Korean Soc Virology 27(2) 209-216.


12. Analysis of the NS4 region of Japanese encephalitis virus K94P05 isolated from Korea. EJ Kim, JH Nam, YK Park, HW Cho. 1997 J Korean Soc Virology 27(2) 197-207.


11. Studies on the duration of immunity and production of antibody following immunization with inactivated killed Japanese encephalitis vaccine. (II) HW Cho, JH Nam, HD Lee, HC Koh, JJ Kim, EJ Kim, SL Chae, YS Lee and JJ Lu. J. Kor. Chi Infec. Assoc. 1997, 40(5). 116-125.




10. Antigenic and genetic analysis of Japanese encephalitis virus isolated from Korea. YJ Chung, JH Nam, SJ Ban, HW Cho. Am. J. Trop. Med. Hyg 1996, 55(1), 91-97.


9. Envelope gene sequence variation among Japanese encephalitis viruses isolated in Korea. JH Nam, YJ Chung, SJ Ban, EJ Kim, YK Park, HW Cho. Acta Virologica 1996, 40, 303-309.


8. Antigenic and genetic differences between the prototype Nakayama-NIH strain and Korean strains of Japanese encephalitis virus. HW Cho, JH Nam, YJ Lee, EJ Kim, HD Lee, HC Koh. J. Kor. Soc. Virology 1996, 26(2) 191-204.


7. The analysis of expression and characterization of JEV envelope gene isolated in Korea. HW Cho, JH Nam, HD Lee, HC Koh, EJ Kim, SL Chae, YS Lee. The Report of National Institute of Health 1996. 33(1) 151-169.


6. Dot blot assay for sequencing of anti-hantavirus antibody by using nucleocapside protein of hantaan virus. HW Cho, YJ Chung, JL Kim, SJ Ban, JH Nam, HY Lee, YJ Lee, EH Kim. J. Kor. Soc. Virology 1996, 26(1) 59-65.


5. The rapid diagnosis of Japanese encephalitis virus isolated in Korea by using dot enzyme immunoassay and RT-PCR. HW Cho, JL Kim, SJ Ban, JH Nam, YJ Chung, EJ Kim, YJ Lee, SE Chae, EH Wong. J. Kor. Soc. Virology 1995, 25(2) 199-206.


4. Studies on the duration of immunity and reactogenicity following immunization with Japanese encephalitis vaccine. (I) HW Cho, JL Kim, SJ Ban, YJ Chung, JH Nam, YJ Lee, EJ Kim, EH Wong, SE Chae. The Report of National Institute of Health 1995 32(1) 151-158.


3. Studies on the pathogenesis of Hemorrhagic fever with renal syndrome. HW Cho, SJ Ban, JH Nam, YJ Chung, JY Hu The Report of National Institute of Health 1994. 30(1) 112-121.


2. The mechanism and band patterns produced by in situ treatments with restriction endonucleases in human chromosomes. JH Nam, SG Lee, TW Wong, SW Lee. Korean J. Genetics 16-3:157-168, 1994.


1. Analysis of SCEs frequency induced by environmental mutagenesis in vitro. SW Lee, JK Nam, JH Nam, BK Lee, EY Kim, SG Lee. Korean J. Environ. Biol. 9(2), 74-87, 1991

연도별 발표논문: 텍스트
bottom of page